Actinic Keratosis is presence
of flaky and scaly patches on surface of the skin causing a premalignant skin
condition mostly dominating fair skinned persons. Segmentation of actinic
kerastosis treatment market by treatment includes fluorouracil, surgical
treatment and others. Dominant exposure to sun-light is one of the prime
reasons for causing actinic keratosis and is observed more in Western than in
Asian countries.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/actinic-keratosis-treatment-market
If left untreated, actinic
keratosis naturally leads to squamous cell carcinoma, a cancerous offshoot and
poses a health hazard with imminent threat to life. Hence preventive therapy
generally calls for early treatment of actinic kerastosis before the onset of
squamous cell carcinoma. Risks surrounding untreated active kerastosis are
greater than treated active kerastosis. Common symptoms of active keratosis are
highly irregular and flaky patches on skin causing burning sensation and rapid
changes in skin color causing skin color to turn a pink hue and adopt a fresh
brown coloration and hard-wart like surface. Skin Biopsy and physical
observations are precursors to diagnosis and confirmation of actinic
kerastosis.
Fluorouracil is further
segmented into imiquimod, diclofenac, ingenol mebutate, and others. Surgical
treatment comprises cryotherapy, scrapping, and others. Based on end-users,
actinic kerastosis treatment market is segmented into hospitals, private
dermatology clinics, oncology centers, ambulatory surgical centers and full
service dermatology centers. Segmentation of actinic keratosis treatment market
by region includes North America, Europe, Asia Pacific, MEA, and Latin America.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/actinic-keratosis-treatment-market/request-sample
No comments:
Post a Comment